Protein Production
293FT, 293E, CHO

Truly Functional Protein
95% Purity
1-10 mg in 2 weeks

GeneExpressoMax™
293Expresso™

Transfection Reagents
* 90% Efficiency
* 95% Viability
* No sera interference
* Simple protocol
* High-throughput
* Only $98/ml

Baculovirus
Functional Protein
95% Purity
Fast turnaround
1-10 mg from Sf9 cells

Adenovirus, AAV
& Lentivirus

ORF or shRNA
* High Titer
* Cre, FLP, ΦC31
* Protein Kinases
* Transcription Factors
* Luciferases, GFP, RFP
* Protein Production
* Stable Cell Line


Excellgen

PET/MRI OF ATHEROSCLEROSIS

Hatsukami Thomas
University Of Washingtoncity: Seattle    country: United States (us)

Grant 5R21HL106061-02 from National Heart, Lung, And Blood Institute

Keywords: Address; Adipose tissue; Animals; Area; Arterial Fatty Streak; Atherosclerosis; base; Biology; Carotid Artery Plaques; Carotid Atherosclerotic Disease; Carotid Endarterectomy; Characteristics; Clinical; Development; Diagnosis; Disease; disease natural history; Evaluation; Event; Exhibits; fluorodeoxyglucose; fluorodeoxyglucose positron emission tomography; Future; Goals; Gold; high risk; Histopathology; Human; Image; imaging modality; Imaging technology; improved; in vivo; Inflammation; Intervention; Lesion; macrophage; Magnetic Resonance Imaging; Measurement; meetings; Methodology; Methods; Molecular; Morphology; Motivation; multimodality; Nature; Pathology; Patients; Perfusion; Pharmacologic Substance; Positron-Emission Tomography; Protocols documentation; public health medicine (field); public health relevance; Recruitment Activity; Research; Resolution; response; Risk; Rupture; Signal Transduction; Source; Specimen; Stratification; Symptoms; Techniques; Testing; Tissues; Tracer; uptake

Relevance: PUBLIC HEALTH NARRATIVE In order for vessel wall imaging methods to meet the clinical need for improved stratification of risk in patients with established lesions of atherosclerosis, those methods must address the underlying pathology that leads to those events. While magnetic resonance imaging provides exceptional information on atherosclerotic plaque morphology, positron emission tomography may be better suited for evaluation of plaque biology, particularly inflammation. The goal of this proposal is to develop a quantitative, reliable, and comprehensive combined MRI PET approach for characterizing carotid artery plaque and inflammation

Project start date: 2011-05-01

Project end date: 2012-12-31

Budget start date: 1-JAN-2012

Budget end date: 31-DEC-2012

5R21HL106061-02 (2012): $224100


Sponsored Links Excellgen http://Excellgen.com

Baculovirus Protein Expression
Fast turn around, >95% purity functional protein. No outsourcing to China or India. $5500, $3950
Recombinant Lentivirus & Adenovirus
High Yield and High Titer up to 1010 (lentivirus) and 1013 (adenovirus) for Guaranteed Expression of GOI. $3000, $2500
Transient Protein Expression in CHO and HEK293 Cells
Transient Expression, Truly Functional Protein, 95% purity, 1~20 mg, fast turnaround. $5500, $3950


Grants awarded to Hatsukami Thomas

PET/MRI OF ATHEROSCLEROSIS

Hatsukami Thomas, Professor
University Of Washingtoncity: Seattle    country: United States (us)

Grant 1R21HL106061-01 from National Heart, Lung, And Blood Institute

Abstract: The central goal of our research is to reduce complications from atherosclerotic disease through the development of imaging technologies. We have previously developed an extensive capability to investigate carotid atherosclerosis via magnetic resonance imaging (MRI). However, our studies have also shown that some aspects of atherosclerotic disease are not easily imaged by MRI, leading us to pursue a multimodality imaging strategy. Most notably, positron emission tomography (PET) scanning offers the possibility to use molecular tracers such as FDG in human studies of atherosclerosis. Thus, combining the capabilities of MRI and PET imaging may offer a more complete picture of atherosclerotic plaque biology. Despite the promise of FDG-PET imaging, considerable challenges exist, most notably related to spatial resolution. Therefore, our central motivation in this proposal is to develop a technique that leverages the high-resolution morphological and perfusion information of MRI to help differentiate the source of FDG-PET signals in carotid atherosclerosis. To investigate this concept, we will utilize high-resolution micro-PET imaging to establish a gold standard of localized signal in ex vivo carotid endarterectomy (CEA) specimens. In order for vessel wall imaging methods to meet the clinical need for improved stratification of risk in patients with established lesions of atherosclerosis, those methods must address the underlying pathology that leads to those events. While magnetic resonance imaging provides exceptional information on atherosclerotic plaque morphology, positron emission tomography may be better suited for evaluation of plaque biology, particularly inflammation. The goal of this proposal is to develop a quantitative, reliable, and comprehensive combined MRI PET approach for characterizing carotid artery plaque and inflammation

Keywords: Address; Adipose tissue; Animals; Area; Arterial Fatty Streak; Atherosclerosis; base; Biology; Carotid Artery Plaques; Carotid Atherosclerotic Disease; Carotid Endarterectomy; Characteristics; Clinical; Development; Diagnosis; Disease; disease natural history; Evaluation; Event; Exhibits; fluorodeoxyglucose; fluorodeoxyglucose positron emission tomography; Future; Goals; Gold; high risk; Histopathology; Human; Image; imaging modality; Imaging technology; improved; in vivo; Inflammation; Intervention; Lesion; macrophage; Magnetic Resonance Imaging; Measurement; meetings; Methodology; Methods; Molecular; Morphology; Motivation; multimodality; Nature; Pathology; Patients; Perfusion; Pharmacologic Substance; Positron-Emission Tomography; Protocols documentation; public health medicine (field); public health relevance; Recruitment Activity; Research; Resolution; response; Risk; Rupture; Signal Transduction; Source; Specimen; Stratification; Symptoms; Techniques; Testing; Tissues; Tracer; uptake

Project start date: 2011-05-01

Project end date: 2012-12-31

Budget start date: 1-MAY-2011

Budget end date: 31-DEC-2011

PFA/PA: PA-10-069

1R21HL106061-01 (2011): $192500